25 May 2021

---

Biolase: Net revenue up 70%

Katherine E. Pfaff

---

Dental laser maker, Biolase, Inc., reported a 70% jump in its first quarter, ending March 31, compared to the same quarter in 2020. The firm cites sales across several areas of the business, including new customers (79%), dental specialties (36%), and increased sales of lasers (139%). Growth was found in several regions, including domestically (67% increase in the US) and globally (75%). 

For the first quarter of the year, net revenue was $8.1 million compared to $4.7 million years over year, a 70% increase. The gross margin for the same periods were 34% and 29%, respectively. 

About Biolase:

Biolase is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Biolase 's products advance the practice of dentistry and medicine for patients and healthcare professionals. Biolase 's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. Biolase 's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. Biolase 's main products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Biolase has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address Biolase 's core dental market and other adjacent medical and consumer applications.

Source: http://www.biolase.com